Viatris Inc. (VTRS)

10.38 -0.05 (-0.48%) 收市：01:00PM EDT

Viatris Inc.

1000 Mylan Boulevard
Canonsburg, PA 15317
United States
724 514 1800
https://www.viatris.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 33,000

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Scott Andrew Smith	CEO & Director	5.07M	無	1962
Mr. Brian S. Roman	Chief Legal Officer	2.51M	無	1971
Ms. Theodora Mistras	Chief Financial Officer	無	無	1982
Mr. Paul B. Campbell	Chief Accounting Officer, Senior VP & Corporate Controller	無	無	1968
Mr. Ramkumar V. Rayapureddy	Chief Information Officer	無	無	無
Mr. Andrew Enrietti	Chief People Officer	無	無	無
Mr. Menassie Taddese M.B.A.	President of Emerging Markets	無	無	1970
Mr. Derek Glover	Chief Quality Officer	無	無	無
Ms. Lara Ramsburg	Chief Corporate Affairs Officer	無	無	無
Dr. Jeffrey Nau MMS, Ph.D.	President of Viatris Eye Care Division	無	無	1976

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

公司管治

截至 2024年7月1日 止，Viatris Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：2；董事會：10；股東權利：6；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。